In early 2022, the state of the art for managing patients with COPD continues to present challenges. When, how, and in whom are inhaled steroids the most effective way to reduce exacerbations? Are the GOLD guidelines still relevant? What do patients with
Managing patients with asthma continues to grow more complex. Two key guidelines have recently been updated. Where do their recommendations concur? Where do they differ, and why? Where do the newer biologic agents fit into evolving treatment paradigms? Wh
Volume 1, Issue 6. In this podcast Dr. Paul Hasson from Johns Hopkins explains the complexity of pulmonary hypertension and the importance of a rigorous diagnostic workup and describes the basic diagnostic algorithm to accurately classify the type of p...
Volume 1, Issue 4. In this podcast, Dr. Nadia Hansel discusses the evidence describing the preferred treatment for symptomatic patients with COPD who have a low risk of exacerbations, describes the evidence for the preferred treatment strategy for pati...
Patient risk factors that are associated with poor medication use in COPD. The high prevalence of medication nonadherence and its negative impact on clinical outcomes in patients with COPD.